Autoimmune Disorders Therapeutics
1. Evoxac patent expiration
Treatment: Treating sjoegren syndrome
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5340821 | COSETTE | Composition and method for treating Sjoegren syndrome disease |
Jul, 2013
(12 years ago) | |
Drugs and Companies using CEVIMELINE HYDROCHLORIDE ingredient
Market Authorisation Date: 11 January, 2000
Dosage: CAPSULE
How can I launch a generic of EVOXAC before it's drug patent expiration?
More Information on Dosage
EVOXAC family patents
